Key result
TAVR linked to ~80% higher risk of death or cerebrovascular events vs. SAVR.
Why the study?
Long-term outcomes comparing transcatheter and surgical aortic valve replacement in patients aged 70 to 89 years with aortic stenosis were unclear.
Does transcatheter aortic valve replacement reduce the composite of all-cause mortality or cerebrovascular events in patients aged 70 to 89 years with aortic stenosis compared to surgical aortic valve replacement?
Cohort (n=1,100)
No
Does transcatheter aortic valve replacement reduce the composite of all-cause mortality or cerebrovascular events in patients aged 70 to 89 years with aortic stenosis compared to surgical aortic valve replacement?
Answers are grounded in this paper and cite their sources.
In patients aged 70 to 89 years with aortic stenosis, TAVR and SAVR showed comparable all-cause mortality, but TAVR was associated with a significantly higher risk of long-term cerebrovascular events.
Objectives To compare long-term outcomes of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients aged 70 to 89 years with aortic stenosis (AS). Methods In this single-center retrospective study, 1100 patients who underwent primary TAVR (n = 599) or SAVR (n = 501) between 2008 and 2023 were included. An overlap-weighted propensity-score analysis was conducted using 36 baseline variables, including age, procedural year, frailty scale, Society of Thoracic Surgeons risk score, New York Heart Association class, history of coronary artery and cerebrovascular disease, and AS severity. The primary end point was the composite of all-cause mortality or cerebrovascular events. Results During long-term follow-up, the composite end point occurred more frequently after TAVR than after SAVR. In the overlap-weighted analysis, TAVR was associated with a greater risk of the composite outcome (hazard ratio [HR], 1.8; 95% CI, 1.1-3.0; P = .024), with Kaplan-Meier curves diverging early and remaining separated. All-cause mortality did not differ between the groups (HR, 1.2; 95% CI, 0.7-2.1; P = .426); however, cerebrovascular events occurred predominantly after TAVR and remained significantly more frequent after overlap weighting (HR, 15; 95% CI, 2.8-89; P = .002). Conclusions In the overlap-weighted population of patients aged 70 to 89 years with AS, SAVR and TAVR were associated with comparable all-cause mortality; however, cerebrovascular events occurred more frequently after TAVR.
No takes yet. Share an insight, caveat, or question.
Kutsuzawa et al. (2026) conducted a cohort in Aortic stenosis (n=1,100). Transcatheter aortic valve replacement (TAVR) vs. Surgical aortic valve replacement (SAVR) was evaluated on Composite of all-cause mortality or cerebrovascular events (HR 1.8, 95% CI 1.1-3.0, p=0.024).
Synapse has enriched 10 related papers. Consider them for comparative context: